300583SZSE
🚨 Material Event

Announcement on Major Litigation of the Company

Saito Biotech Co., Ltd.··3 pages

✨ AI Summary

Shandong Saile Bio-Tech Co., Ltd. has filed a civil lawsuit as the plaintiff against five defendants for infringement of trade secrets. The company seeks to stop the infringement and claims 320 million RMB in damages. The company believes the lawsuit is a legitimate measure to protect its rights and will not significantly impact its operations, though the final financial outcome remains uncertain pending the court's decision.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 300583

Securities Abbreviation: Saile Bio-Tech

Announcement No.: 2026-039

Shandong Saile Bio-Tech Co., Ltd.

Announcement on Major Litigation of the Company

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

Key Information Prompt:

  1. Litigation Stage: The court has accepted the case and has not yet formally opened a trial.

  2. Party Status of the Listed Company: Shandong Saile Bio-Tech Co., Ltd. (hereinafter referred to as the "Company") is the plaintiff.

  3. Amount Involved: The amount claimed by the plaintiff is RMB 320 million.

  4. Impact on the Company's Profit and Loss: This lawsuit is initiated by the Company due to the infringement of its trade secrets. It is a legitimate measure taken by the Company to protect its legitimate rights and interests. It is not expected to have a significant adverse impact on the Company's operations. The Company will actively respond and use legal channels to effectively protect the legitimate rights and interests of the Company and its shareholders. The case has not yet been heard in court. The specific impact of this litigation on the Company's current or future profits is uncertain, and the final actual impact will depend on the court's judgment and execution. The Company will fulfill its information disclosure obligations in a timely manner based on the progress of the case.

I. Basic Situation of the Acceptance of This Major Litigation

The Company, as the plaintiff, has filed a civil lawsuit with the Shandong Provincial Higher People's Court regarding the infringement of its trade secrets. The Shandong Provincial Higher People's Court has accepted the case recently.

Plaintiff: Shandong Saile Bio-Tech Co., Ltd.

Defendant 1: Shenyang Botai Pharmaceutical Co., Ltd.

Defendant 2: Chang Zunxue

Defendant 3: Liu Yao

Defendant 4: Liu Liang

Defendant 5: Liu Yanling

II. Basic Case Information

(I) Cause of Action: Infringement of Trade Secrets Dispute

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.